Literature DB >> 3084532

Interferon-gamma induces the expression of HLA-A,B,C but not HLA-DR on human pancreatic beta-cells.

I L Campbell, K Bizilj, P G Colman, B E Tuch, L C Harrison.   

Abstract

We examined the effect of interferon-gamma (IFN gamma) on expression of the major histocompatibility proteins on cultured human islet cells isolated from adult and fetal pancreas and from an insulinoma. While the pancreatic beta-cells from different sources varied in their responses to IFN gamma, in all instances the expression of HLA-A,B,C protein was increased. Pancreatic beta-cells did not express HLA-DR protein, before or after culture of the islets in IFN gamma, although HLA-DR protein expression was induced on some non-beta-cells. These findings are at variance with those reported with thyroid follicular cells, in which IFN gamma induced expression of HLA-DR. We, therefore, conclude that the interaction between the immune and the endocrine systems may be endocrine cell specific. The up-regulation of HLA-A,B,C protein on beta-cells by IFN gamma provides a mechanism for enhanced targetting to the beta-cells of autoreactive cytotoxic T-lymphocytes and, hence, for amplifying beta-cell destruction.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084532     DOI: 10.1210/jcem-62-6-1101

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

1.  Pancreatic beta cells persistently infected with coxsackievirus B4 are targets of NK cell-mediated cytolytic activity.

Authors:  Magloire Pandoua Nekoua; Antoine Bertin; Famara Sane; Enagnon Kazali Alidjinou; Delphine Lobert; Jacques Trauet; Christine Hober; Ilka Engelmann; Kabirou Moutairou; Akadiri Yessoufou; Didier Hober
Journal:  Cell Mol Life Sci       Date:  2019-06-06       Impact factor: 9.261

2.  Class I and II major histocompatibility complex gene product expression by a rat insulinoma cell line in vitro following exposure to gamma interferon.

Authors:  B Issa-Chergui; A Goldner-Sauvé; E Colle; G J Prud'homme; P H Lapchak; P H van der Meide; T A Seemayer
Journal:  Diabetologia       Date:  1988-09       Impact factor: 10.122

Review 3.  Immunopathology of the human pancreas in type-I diabetes.

Authors:  Sarah J Richardson; Abby Willcox; Adrian J Bone; Noel G Morgan; Alan K Foulis
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

Review 4.  The role of immunotherapy in type I diabetes mellitus.

Authors:  M E Geffner; B M Lippe
Journal:  West J Med       Date:  1987-03

5.  Nonimmune thyroid destruction results from transgenic overexpression of an allogeneic major histocompatibility complex class I protein.

Authors:  A G Frauman; P Chu; L C Harrison
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

6.  Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice.

Authors:  I L Campbell; T W Kay; L Oxbrow; L C Harrison
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

7.  Mumps virus infects beta cells in human fetal islet cell cultures upregulating the expression of HLA class I molecules.

Authors:  P Parkkonen; H Hyöty; L Koskinen; P Leinikki
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

8.  Immunogenicity of human embryonic stem cell-derived beta cells.

Authors:  Cornelis R van der Torren; Arnaud Zaldumbide; Gaby Duinkerken; Simone H Brand-Schaaf; Mark Peakman; Geert Stangé; Laura Martinson; Evert Kroon; Eugene P Brandon; Daniel Pipeleers; Bart O Roep
Journal:  Diabetologia       Date:  2016-10-27       Impact factor: 10.122

9.  Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma.

Authors:  N Sarvetnick; D Liggitt; S L Pitts; S E Hansen; T A Stewart
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

10.  Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p.

Authors:  Guoping Ding; Liangjing Zhou; Yingming Qian; Mingnian Fu; Jian Chen; Jionghuang Chen; Jianyang Xiang; Zhengrong Wu; Guixing Jiang; Liping Cao
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.